BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37874744)

  • 21. Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.
    Antić Ž; Yu J; Bornhauser BC; Lelieveld SH; van der Ham CG; van Reijmersdal SV; Morgado L; Elitzur S; Bourquin JP; Cazzaniga G; Eckert C; Camós M; Sutton R; Cavé H; Moorman AV; Sonneveld E; Geurts van Kessel A; van Leeuwen FN; Hoogerbrugge PM; Waanders E; Kuiper RP
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29361. PubMed ID: 34597466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
    Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia.
    Sun J; Yu W; Zhang X
    Biomark Res; 2020 Nov; 8(1):62. PubMed ID: 33292784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.
    Hnízda A; Fábry M; Moriyama T; Pachl P; Kugler M; Brinsa V; Ascher DB; Carroll WL; Novák P; Žaliová M; Trka J; Řezáčová P; Yang JJ; Veverka V
    Leukemia; 2018 Jun; 32(6):1393-1403. PubMed ID: 29535428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.
    Oshima K; Zhao J; Pérez-Durán P; Brown JA; Patiño-Galindo JA; Chu T; Quinn A; Gunning T; Belver L; Ambesi-Impiombato A; Tosello V; Wang Z; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Balbin M; Nicolas C; Gastier-Foster JM; Devidas M; Loh ML; Paietta E; Tallman MS; Rowe JM; Litzow M; Minden MD; Meijerink J; Rabadan R; Ferrando A
    Nat Cancer; 2020 Nov; 1(11):1113-1127. PubMed ID: 33796864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.
    Malinowska-Ozdowy K; Frech C; Schönegger A; Eckert C; Cazzaniga G; Stanulla M; zur Stadt U; Mecklenbräuker A; Schuster M; Kneidinger D; von Stackelberg A; Locatelli F; Schrappe M; Horstmann MA; Attarbaschi A; Bock C; Mann G; Haas OA; Panzer-Grümayer R
    Leukemia; 2015 Aug; 29(8):1656-67. PubMed ID: 25917266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal evolution of acute leukemia genomes.
    Jan M; Majeti R
    Oncogene; 2013 Jan; 32(2):135-40. PubMed ID: 22349821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine.
    Chang YL; Chen HY; Chen KB; Chen KC; Chang KL; Chang PC; Chang TT; Chen YC
    SAR QSAR Environ Res; 2016 Jul; 27(7):589-608. PubMed ID: 27218135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization.
    Narang S; Evensen NA; Saliba J; Pierro J; Loh ML; Brown PA; Kolekar P; Mulder H; Shao Y; Easton J; Ma X; Tsirigos A; Carroll WL
    Genome Biol; 2023 Apr; 24(1):64. PubMed ID: 37016431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia
    Saliba J; Evensen NA; Meyer JA; Newman D; Nersting J; Narang S; Ma X; Schmiegelow K; Carroll WL
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28306. PubMed ID: 32391957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
    Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
    Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into the clinical characteristics of SETD2-mutated acute myeloid leukaemia.
    Zhang X; Wang Z; Sun J; Liu L; Qin J; Huang A; Yang M; Lou Y; Tang G; Mao L; Qian J; Wei J; Mai W; Meng H; Yang J; Tong H; Wang J; Yu W; Ni X; Jin J
    Br J Haematol; 2023 Jul; 202(1):111-115. PubMed ID: 37038274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia.
    Sayyab S; Lundmark A; Larsson M; Ringnér M; Nystedt S; Marincevic-Zuniga Y; Tamm KP; Abrahamsson J; Fogelstrand L; Heyman M; Norén-Nyström U; Lönnerholm G; Harila-Saari A; Berglund EC; Nordlund J; Syvänen AC
    Sci Rep; 2021 Aug; 11(1):15988. PubMed ID: 34362951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia.
    Gump J; McGavran L; Wei Q; Hunger SP
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):416-9. PubMed ID: 11878574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Expression and Activation of the NF-κB Pathway Correlate with Methotrexate Resistance and Cell Proliferation in Acute Lymphoblastic Leukemia.
    Canevarolo RR; Cury NM; Yunes JA
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.
    Meyer JA; Wang J; Hogan LE; Yang JJ; Dandekar S; Patel JP; Tang Z; Zumbo P; Li S; Zavadil J; Levine RL; Cardozo T; Hunger SP; Raetz EA; Evans WE; Morrison DJ; Mason CE; Carroll WL
    Nat Genet; 2013 Mar; 45(3):290-4. PubMed ID: 23377183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.